Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers

Supportive Care in Cancer

Volumn 22, Issue 5, 2014, Pages 1189-1197

  Kao, Hsiang Fong ^a   Chen, I Chun ^a   Hsu, Chiun ^a   Chang, Sin Yuan ^a   Chien, Shu Fen ^a   Chen, Yee Chun ^a   Hu, Fu Chang ^b   Yang, James Chih Hsin ^a,b   Cheng, Ann Lii ^a,b   Yeh, Kun Huei ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Catheterization; Central venous adverse effects; Chlorhexidine; Neoplasms adverse effects; Povidone iodine

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORHEXIDINE; POVIDONE IODINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; BREAST CANCER; CANCER CHEMOTHERAPY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OVERALL SURVIVAL; PATHOGENESIS; PORT A ASSOCIATED BLOODSTREAM INFECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SKIN DECONTAMINATION; SOLID TUMOR; TOPICAL TREATMENT;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS, LOCAL; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHLORHEXIDINE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POVIDONE-IODINE; YOUNG ADULT;

EID: 84897485765     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-2071-5     Document Type: Article

References (30)

1. Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767-773 (Pubitemid 28394164)
2. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH (2005) Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 41:1591-1598 (Pubitemid 41693760)
3. Renaud B, Brun-Buisson C (2001) Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163:1584-1590 (Pubitemid 32578760)
4. Chen IC, Hsu C, Chen YC, Chien SF, Kao HF, Chang SY, Hu FC, Yeh KH (2013) Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients. Ann Oncol 24:463-468
5. Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159-1171 (Pubitemid 44316281)
6. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1-45
7. Raad I, Hanna H, Maki D (2007) Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7:645-657 (Pubitemid 47444563)
8. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA (2007) Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 167:2073-2079 (Pubitemid 350036706)
9. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162-e193
10. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA (2006) Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 166:306-312 (Pubitemid 43244318)
11. Ramphal R (2004) Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39(Suppl 1):S25-S31
12. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103-1110 (Pubitemid 36553108)
13. Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G (2008) Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 61:721-728 (Pubitemid 351321152)
14. Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh PR (2010) Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect 138:1044-1051
15. Kang CI, Song JH, Chung DR, Peck KR, Yeom JS, Son JS, Wi YM (2012) Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia. Support Care Cancer 20:2371-2378
16. Montassier E, Batard E, Gastinne T, Potel G, de La Cochetiere MF (2013) Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 32:841-850
17. Lim KS, Kam PC (2008) Chlorhexidine - pharmacology and clinical applications. Anaesth Intensive Care 36:502-512
18. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, Crosby CT, Mosier MC, Alsharif A, Berger DH (2010) Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Eng J Med 362:18-26
19. Soofi S, Cousens S, Imdad A, Bhutto N, Ali N, Bhutta ZA (2012) Topical application of chlorhexidine to neonatal umbilical cords for prevention of omphalitis and neonatal mortality in a rural district of Pakistan: a community-based, cluster-randomised trial. Lancet 379:1029-1036
20. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S (2002) Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136:792-801 (Pubitemid 34568649)
21. Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, Herault MC, Haouache H, Calvino-Gunther S, Gestin B, Armand-Lefevre L, Leflon V, Chaplain C, Benali A, Francais A, Adrie C, Zahar JR, Thuong M, Arrault X, Croize J, Lucet JC (2009) Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 301:1231-1241
22. Chuang YC, Chen YC, Chang SC, Sun CC, Chang YY, Chen ML, Hsu LY, Wang JT (2010) Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981-2007. J Hosp Infect 76:143-149
23. Eggimann P (2007) Diagnosis of intravascular catheter infection. Curr Opin Infect Dis 20:353-359
24. Shen YC, Hsu C, Chen LT, Cheng CC, Hu FC, Cheng AL (2010) Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach. J Hepatol 52:889-894
25. D'Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265-2281
26. Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas C (2010) Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 75:1-11
27. van de Wetering MD, van Woensel JB (2007) Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev 24, CD003295
28. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83-93 (Pubitemid 351920592)
29. D'Agostino RB Jr, D'Agostino RB Sr (2007) Estimating treatment effects using observational data. JAMA 297:314-316
30. Novikov I, Kalter-Leibovici O (2007) Analytic approaches to observational studies with treatment selection bias. JAMA 297:2077